<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03138174</url>
  </required_header>
  <id_info>
    <org_study_id>WI3052203</org_study_id>
    <nct_id>NCT03138174</nct_id>
  </id_info>
  <brief_title>OneTouch Verio Flex System Accuracy Evaluation</brief_title>
  <acronym>OTVFSA</acronym>
  <official_title>OneTouch Verio Flex System Accuracy Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LifeScan</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LifeScan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical System Accuracy Evaluation of the CE Marked One Touch Verio Flex blood glucose
      monitoring device as per requirements stated in ISO 15197:2015. To meet the requirements,
      glucose samples must be distributed over the operating range of the blood glucose monitor as
      stipulated in ISO:15197
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical System Accuracy Evaluation of the CE Marked One Touch Verio Flex blood glucose
      monitoring device as per requirements stated in ISO 15197:2015.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 23, 2017</start_date>
  <completion_date type="Actual">May 2, 2017</completion_date>
  <primary_completion_date type="Actual">May 2, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To meet the requirements of ISO 15197:2015</measure>
    <time_frame>Four weeks</time_frame>
    <description>In order to meet the requirements of ISO 15197:2015
For each lot individually, 95% of the individual glucose results shall fall within either +0.83 mmol/L (+ 15 mg/dL) of the average measured values of the reference measurement procedure at glucose concentration intervals &lt; 5.55 mmol/L (&lt; 100 mg/dL) or within + 15 % at glucose concentrations &gt; 5.55 mmol/L (&gt; 100 mg/dL).
99% of individual glucose measured values shall fall within zones A and B of the Consensus Error Grid for type 1 diabetes.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Diabetes</arm_group_label>
    <description>One group consisting of diabetic subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OneTouch Verio Flex Blood Glucose Monitoring System</intervention_name>
    <description>Blood Glucose Monitoring System</description>
    <arm_group_label>Diabetes</arm_group_label>
  </intervention>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Capillary blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will consist of subjects diagnosed with diabetes
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Summary of Inclusion Criteria:

          -  All Subjects must be registered into the LFSS Patient Registry to participate in the
             study.

          -  Each Participant must read and sign the approved Informed Consent Form.

          -  Diabetes Diagnosis - Participants should be diagnosed with some form of diabetes for
             system accuracy.

        Summary of Exclusion Criteria:

        &gt; Subjects not enrolled in the LFSS Patient Registry are not eligible to participate in the
        study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alan Patrick</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Health Service, United Kingdom</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Diabetes Centre, Birmingham Heartlands Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Highland Diabetes Institute</name>
      <address>
        <city>Inverness</city>
        <zip>IV2 3JH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2017</study_first_submitted>
  <study_first_submitted_qc>April 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2017</study_first_posted>
  <last_update_submitted>June 27, 2017</last_update_submitted>
  <last_update_submitted_qc>June 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Blood Glucose Monitor System Accuracy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>De identified data may be shared by way of study reports and publications</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

